Margaret G. McGlynn, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 9,200 shares at $241.83 ($2.2M) on 2022-01-28, disclosed to the SEC on 2022-02-01.
Open-market sale of $2.2M VRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $240.53 | 1,901 | $457K | 20.6% |
| 2 | $240.53 | 1,901 | $457K | 20.6% |
| 3 | $241.83 | 800 | $193K | 8.7% |
| 4 | $242.78 | 2,087 | $507K | 22.8% |
| 5 | $242.78 | 2,087 | $507K | 22.8% |
| 6 | $243.24 | 212 |
| $52K |
| 2.3% |
| 7 | $243.24 | 212 | $52K | 2.3% |
| Total | $241.79 avg | 9,200 | $2.2M | 100% |
| Filing → |
| FOLD | SELL | 2022-05-04 | $105K | — | Filing → |
| VRTX | SELL | 2022-04-12 | $1.4M | — | Filing → |
| VRTX | SELL | 2022-04-04 | $2.6M | — | Filing → |